2000
DOI: 10.1046/j.1365-2559.2000.00851.x
|View full text |Cite
|
Sign up to set email alerts
|

Basaloid squamous carcinoma of the oesophagus: a distinct neoplasm with multipotential differentiation

Abstract: Basaloid squamous carcinoma of the oesophagus is a peculiar neoplasm with a capacity of multidirectional differentiation, often with heterogeneous oncogene expression, probably reflecting the pluripotential stem cell origin.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

2
54
0
10

Year Published

2006
2006
2024
2024

Publication Types

Select...
3
3
2

Relationship

0
8

Authors

Journals

citations
Cited by 67 publications
(66 citation statements)
references
References 25 publications
2
54
0
10
Order By: Relevance
“…However, several recent reports (Li et al, 2004;Kobayashi et al, 2009) have demonstrated that BSCCE was accompanied by various histopathological components including ductal differentiation, myoepithelial cells, and adenoid cystic carcinoma-like features in some cases. Furthermore, some BSCCE had concomitant in situ or invasive SCC components and even the presence of small cell carcinoma (Cho et al, 2000), and therefore requires careful differentiation. Some reporters (Sarbia et al, 1997;Morice et al, 1998;Cho et al, 2000) have stated that the immunoreactivities for cytokeratin subtypes, Bcl-2, beta-catenin, S-100, and neuroendocrine markers, are different among these tumors and might assist in the distinction.…”
Section: Discussionmentioning
confidence: 99%
See 2 more Smart Citations
“…However, several recent reports (Li et al, 2004;Kobayashi et al, 2009) have demonstrated that BSCCE was accompanied by various histopathological components including ductal differentiation, myoepithelial cells, and adenoid cystic carcinoma-like features in some cases. Furthermore, some BSCCE had concomitant in situ or invasive SCC components and even the presence of small cell carcinoma (Cho et al, 2000), and therefore requires careful differentiation. Some reporters (Sarbia et al, 1997;Morice et al, 1998;Cho et al, 2000) have stated that the immunoreactivities for cytokeratin subtypes, Bcl-2, beta-catenin, S-100, and neuroendocrine markers, are different among these tumors and might assist in the distinction.…”
Section: Discussionmentioning
confidence: 99%
“…Furthermore, some BSCCE had concomitant in situ or invasive SCC components and even the presence of small cell carcinoma (Cho et al, 2000), and therefore requires careful differentiation. Some reporters (Sarbia et al, 1997;Morice et al, 1998;Cho et al, 2000) have stated that the immunoreactivities for cytokeratin subtypes, Bcl-2, beta-catenin, S-100, and neuroendocrine markers, are different among these tumors and might assist in the distinction. However, none of these markers are specific for BSCCE.…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…The incidences of BSCC differ according to reports, ranging from 0.77% to 5% in Asian groups [1][2][3][4][5][6] and from 6.9% to 11.3% in Western groups. 7,8) In 332 esophageal cancer cases who underwent surgical resection at our department between 1987 and 2010 nine cases (2.7%) were diagnosed as BSCC.…”
Section: Discussionmentioning
confidence: 99%
“…O carcinoma basalóide escamoso (CBE) é uma variante incomum do carcinoma de células escamosas do esôfago (CEC), com características clínicas próprias, sendo a alta agressividade biológica e o mau prognóstico os atributos de maior destaque 2,4,10 . Este tipo de neoplasia ocorre com maior freqüência no trato aerodigestivo superior, tendo como sítios primários preferenciais a cavidade oral, faringe, laringe, seio piriforme e traquéia 5,8,14 .…”
Section: Introductionunclassified